Amyl Therapeutics logo

Amyl Therapeutics

ID: 7683407

Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases

3

Funding Rounds

$33.6m

Money raised

Overview

Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Amyl Therapeutics has raised a total of $33.6m in funding over 3 rounds.

Key Insights:

  • Amyl Therapeutics November 2023 Series A Funding Round: $5.7m
  • Amyl Therapeutics November 2023 Series A Funding Round: $5.7m
  • Amyl Therapeutics Series A round, June 2021: $22.2m